• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO 25T; TEST, HIV DETECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO 25T; TEST, HIV DETECTION Back to Search Results
Catalog Number 7D2648
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/03/2024
Event Type  malfunction  
Event Description
The customer reported a false negative result with the determine hiv 1/2 ag/ab combo 25t performed on or before (b)(6) 2024 on an unknown sample type.Additional testing was performed on the same day via insti kit hiv antibody test which generated a positive result.The patient was known to be hiv positive and has been receiving ¿hiv care¿ since 2016.It is unknown if the patient has been receiving antiretroviral (art) therapy.The patient is confirmed to not use biotin.Although requested, no additional information, including patient treatment and outcome, was provided.
 
Manufacturer Narrative
B3: the date provided is an approximation as the exact event date was not provided.D4-udi:(b)(4).The remainder of the investigation remains in progress.A supplemental report will be provided after completion.H3 other text : single use; device discarded.
 
Event Description
The customer reported a false negative result with the determine hiv 1/2 ag/ab combo 25t performed on 03jan2024 on a blood sample.Additional testing was performed on the same day via insti kit hiv antibody test which generated a positive result.The patient was known to be hiv positive and has been receiving ¿hiv care¿ since 2016.It is unknown if the patient has been receiving antiretroviral (art) therapy.The patient is confirmed to not use biotin.The customer confirmed there was no harm due to the test results.Additionally, the customer confirmed there was no delay or impact in treatment.
 
Manufacturer Narrative
D4-udi:(b)(4) testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 794260 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 7d2648/ lot: 794260, test base part number 10732998/ lot: 784893.The lot met the required release specifications.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 794260 showed that the complaint rate is(b)(4).Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue.D4- corrected gtin to 00811877011101 h10-corrected udi to (b)(4)h3 other text : single use; device discarded.
 
Event Description
The customer reported a false negative result with the determine hiv 1/2 ag/ab combo 25t performed on (b)(6)2024 on a blood sample.Additional testing was performed on the same day via insti kit hiv antibody test which generated a positive result.The patient was known to be hiv positive and has been receiving ¿hiv care¿ since 2016.It is unknown if the patient has been receiving antiretroviral (art) therapy.The patient is confirmed to not use biotin.The customer confirmed there was no harm due to the test results.Additionally, the customer confirmed there was no delay or impact in treatment.
 
Manufacturer Narrative
Additional information received: a2,a3, a5, &a6-patient information specified b2-date of occurrence specified b5-update on patient impact/treatment h6: health effect - impact code changed to f26 d4-udi(b)(4) the remainder of the investigation remains in progress.A supplemental report will be provided after completion.H3 other text : single use; device discarded.
 
Manufacturer Narrative
D4-udi(b)(4) testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 794260 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 7d2648/ lot: 794260, test base part number 10732998/ lot: 784893.The lot met the required release specifications.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 794260 showed that the complaint rate is(b)(4).Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue.H3 other text : single use; device discarded.
 
Event Description
The customer reported a false negative result with the determine hiv 1/2 ag/ab combo 25t performed on (b)(6)2024 on a blood sample.Additional testing was performed on the same day via insti kit hiv antibody test which generated a positive result.The patient was known to be hiv positive and has been receiving ¿hiv care¿ since 2016.It is unknown if the patient has been receiving antiretroviral (art) therapy.The patient is confirmed to not use biotin.The customer confirmed there was no harm due to the test results.Additionally, the customer confirmed there was no delay or impact in treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE DETERMINE HIV 1/2 AG/AB COMBO 25T
Type of Device
TEST, HIV DETECTION
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key18511270
MDR Text Key333341024
Report Number1221359-2024-00062
Device Sequence Number1
Product Code MZF
UDI-Device Identifier00811877011101
UDI-Public00811877011101
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP120037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 03/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number7D2648
Device Lot Number794260
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/04/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/06/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age34 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-